These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17435946)

  • 1. Was the exacerbation of PTSD symptoms after high doses of venlafaxine due to the noradrenergic mechanism? A case report.
    da Rocha FF; Correa H
    Braz J Psychiatry; 2007 Mar; 29(1):94. PubMed ID: 17435946
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.
    Hamner MB; Frueh BC
    Int Clin Psychopharmacol; 1998 Sep; 13(5):233-4. PubMed ID: 9817630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant use during pregnancy. FPIN’s clinical inquiries.
    Patel BN; Beste J; Blackwell JC
    Am Fam Physician; 2011 May; 83(10):1211-5. PubMed ID: 21568258
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 5. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence-based pharmacoanalytics of using venlafaxine in clinical medicine].
    Rachin AP; Sergeev AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):68-70. PubMed ID: 19938277
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.
    Hanekamp BB; Zijlstra JG; Tulleken JE; Ligtenberg JJ; van der Werf TS; Hofstra LS
    Neth J Med; 2005 Sep; 63(8):316-8. PubMed ID: 16186642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.
    Papadimitriou GN; Theleritis CG; Papageorgiou CC; Kalogeromitros D; Syrigou E; Gregoriou S; Rabavilas AD
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1019. PubMed ID: 16922966
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of antidepressants among children and adolescents--did the warnings lead to fewer prescriptions?].
    Bramness JG; Engeland A; Furu K
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2653-5. PubMed ID: 17952146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship with venlafaxine.
    Kelsey JE
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):21S-26S; discussion 26S-28S. PubMed ID: 8784645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
    McIntyre A; Gendron A; McIntyre A
    Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bupropion with SRIs and venlafaxine.
    Spier SA
    Depress Anxiety; 1998; 7(2):73-5. PubMed ID: 9614595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psycho- and pharmacotherapy of depressions. So you combine correctly].
    Arnheim K
    MMW Fortschr Med; 2009 May; 151(19):20. PubMed ID: 19827439
    [No Abstract]   [Full Text] [Related]  

  • 18. [Discontinuation of antidepressant serotonergic antidepressant].
    Andersen CL; Videbech P
    Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Jaffe IA
    Lancet; 1995 May; 345(8961):1378. PubMed ID: 7752794
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is there a relationship between clinical efficacy and antidepressant dosage in major depression?].
    Corruble E; Guelfi JD
    Encephale; 1999 Jun; 25 Spec No 2():39-43; discussion 44-6. PubMed ID: 10434158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.